Reply to Gleicher and Barad: Noninvasive preimplantation genetic testing may provide the solution to the problem of embryo mosaicism
Year: 2019
Type: letter
Abstract: We thank Drs. Gleicher and Barad for their interest in our recent paper, in which we report a higher reliability of noninvasive preimplantation genetic testing for aneuploidy (niPGT-A) in spent medium compared with conventional trophectoderm (TE) biopsy (1). However, we respectfully disagree with their comments.
The main points raised by Gleicher and Barad are that PGT-A, whether invasive or not, is not a useful test for ploidy because correction of chromosomal errors occurs downstream of blastocyst formation, and that this accounts for the high incidence of false positives associated with TE biopsy (2). We disagree that “self-correction” largely explains the high false-positive rate with the TE biopsy …
[↵][1]1To whom correspondence may be addressed. Email: sunneyxie{at}pku.edu.cn.
[1]: #xref-corresp-1-1
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2977810860
